STOCK TITAN

TELA Bio (TELA) grants director new RSUs and stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TELA Bio director Betty Jo Rocchio received new equity awards. She was granted 11,675 restricted stock units of common stock, increasing her direct common stock holdings to 23,600 shares after the award. These units vest on the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, subject to her continued service.

She also received a stock option covering 17,335 shares of common stock at an exercise price of $0.935 per share, expiring on June 9, 2036. This option vests on the same schedule and service conditions as the restricted stock units.

Positive

  • None.

Negative

  • None.
Insider Rocchio Betty Jo
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 17,335 $0.00 --
Grant/Award Common Stock 11,675 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 17,335 shares (Direct, null); Common Stock — 23,600 shares (Direct, null)
Footnotes (1)
  1. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
RSU grant 11,675 units Restricted stock units granted June 9, 2026
Common shares after grant 23,600 shares Direct common stock held after RSU award
Option grant size 17,335 shares Stock option covering common shares
Option exercise price $0.935 per share Strike price for stock option granted June 9, 2026
Option expiration June 9, 2036 Expiration date of stock option grant
RSU vesting date June 9, 2027 Latest possible vesting date, subject to earlier triggers
restricted stock units financial
"These restricted stock units vest on the earlier of (a) June 9, 2027..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Change in Control financial
"or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan)..."
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated 2019 Equity Incentive Plan financial
"Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan)..."
stock option financial
"The option vests on the earlier of (a) June 9, 2027..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rocchio Betty Jo

(Last)(First)(Middle)
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24

(Street)
MALVERN PENNSYLVANIA 19355

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026A11,675(1)A$023,600D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.93506/09/2026A17,335 (2)06/09/2036Common Stock17,335$017,335D
Explanation of Responses:
1. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
2. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Megan Smeykal, Attorney-in-Fact06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did TELA Bio (TELA) grant to director Betty Jo Rocchio?

TELA Bio granted director Betty Jo Rocchio 11,675 restricted stock units and a stock option for 17,335 shares at a $0.935 exercise price. Both awards are compensation-related grants, not open‑market purchases or sales, and were issued on June 9, 2026.

How do the new grants affect Betty Jo Rocchio’s TELA Bio share holdings?

After receiving 11,675 restricted stock units, Betty Jo Rocchio directly holds 23,600 shares of TELA Bio common stock. She also holds a new option for 17,335 shares, which is a derivative right and does not count as owned common stock until exercised.

When do Betty Jo Rocchio’s new TELA Bio restricted stock units vest?

The 11,675 restricted stock units vest on the earlier of June 9, 2027, the next annual meeting of stockholders, or a Change in Control. Vesting in each case requires her continued service through the applicable vesting date under the company’s equity plan.

What are the key terms of Betty Jo Rocchio’s new TELA Bio stock option?

The new stock option covers 17,335 shares of TELA Bio common stock at a $0.935 exercise price and expires on June 9, 2036. It vests on the earlier of June 9, 2027, the next annual stockholder meeting, or a qualifying Change in Control, conditioned on continued service.

Are Betty Jo Rocchio’s TELA Bio Form 4 transactions open‑market buys or sells?

No, the Form 4 shows compensation grants, not market trades. Both the restricted stock units and stock option are coded as awards (transaction code A), reflecting equity compensation grants rather than open‑market purchases or sales of TELA Bio shares.